{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:04:54Z","timestamp":1791140694702,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:p>Uterine sarcomas represent a clinical challenge because of their difficult diagnosis and the poor prognosis of certain subtypes. The aim of this study was to evaluate the expression of the special AT-rich sequence-binding protein 2 (SATB2) in endometrial stromal sarcoma (ESS) and other types of uterine sarcoma by immunohistochemistry. We studied the expression of SATB2 on 71 full tissue sections of endometrial stromal nodule, low-grade ESS, uterine leiomyomas and leiomyosarcoma, undifferentiated uterine sarcoma, adenosarcoma, and carcinosarcoma samples. Nuclear SATB2 expression was then evaluated in an extended sample set using a tissue microarray, including 78 additional uterine tumor samples. Overall, with a cut-off of \u226510% of tumor cell staining as positive, the nuclear SATB2 score was negative in all endometrial stromal nodule samples (n=10) and positive in 83% of low-grade ESS samples (n=29\/35), 40% of undifferentiated uterine sarcoma (n=4\/10), 13% of leiomyosarcoma (n=2\/16), 14% of adenosarcoma (n=3\/22), and 8% carcinosarcoma (n=2\/25) samples. Furthermore, in ESS patients, direct comparison of nuclear SATB2 scores with clinicopathologic parameters and other reported biomarkers such as progesterone receptor and estrogen receptor showed that nuclear SATB2 was associated with PR expression and a decreased risk of disease-specific death (odds ratio=0.06, 95% confidence interval=0.04\u20130.81, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.04). Our data suggest that SATB2 could be a marker with relative sensitivity (83%) for distinguishing between endometrial stromal nodule and ESS with potential prognostic value.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000730","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T11:02:27Z","timestamp":1615806147000},"page":"487-494","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study"],"prefix":"10.1097","volume":"40","author":[{"given":"C\u00e9cile","family":"Le Page","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorah","family":"Almadani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulisa","family":"Turashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bataillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Portelance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Mes-Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lien","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurosh","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,3,13]]},"reference":[{"key":"R1-20250802","first-page":"399","article-title":"The epidemiology of sarcomas of the uterus","volume":"76","author":"Harlow","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/modpathol.3880055","article-title":"Smooth muscle, endometrial stromal, and mixed Mullerian tumors of the uterus","volume":"13","author":"Kempson","year":"2000","journal-title":"Mod Pathol"},{"issue":"suppl 1","key":"R3-20250802","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1038\/modpathol.2015.140","article-title":"Practical issues related to uterine pathology: endometrial stromal tumors","volume":"29","author":"Nucci","year":"2016","journal-title":"Mod Pathol"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.path.2019.01.004","article-title":"Uterine mesenchymal tumors: update on classification, staging, and molecular features","volume":"12","author":"Parra-Herran","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/ijgc-00009577-200211000-00001","article-title":"Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas","volume":"12","author":"McCluggage","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.4675","article-title":"Uterine adenosarcomas are mesenchymal neoplasms","volume":"238","author":"Piscuoglio","year":"2016","journal-title":"J Pathol"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/PGP.0000000000000593","article-title":"Uterine endometrial stromal tumors with limited infiltration: first report of a case series indicating potential for malignant behavior","volume":"39","author":"Moore","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00428-018-2470-6","article-title":"Recent advances in the histological and molecular classification of endometrial stromal neoplasms","volume":"473","author":"Ferreira","year":"2018","journal-title":"Virchows Arch"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","article-title":"Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pathol.2017.11.086","article-title":"Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations","volume":"50","author":"Hoang","year":"2018","journal-title":"Pathology"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/cas.13613","article-title":"Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma","volume":"109","author":"Tsuyoshi","year":"2018","journal-title":"Cancer Sci"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/s41379-019-0265-1","article-title":"SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer","volume":"32","author":"Ma","year":"2019","journal-title":"Mod Pathol"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41388-018-0541-4","article-title":"SATB family chromatin organizers as master regulators of tumor progression","volume":"38","author":"Naik","year":"2019","journal-title":"Oncogene"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/jcar.JCar_8_17","article-title":"Oncogenic and tumor suppressive roles of special AT-rich sequence-binding protein","volume":"17","author":"Chen","year":"2018","journal-title":"J Carcinog"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/PGP.0000000000000544","article-title":"SATB2 is consistently expressed in squamous morules associated with endometrioid proliferative lesions and in the stroma of atypical polypoid adenomyoma","volume":"38","author":"McCluggage","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cjp2.131","article-title":"A COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma","volume":"5","author":"Le Page","year":"2019","journal-title":"J Pathol Clin Res"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s41379-019-0302-0","article-title":"A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases","volume":"12","author":"Meagher","year":"2019","journal-title":"Mod Pathol"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/his.12911","article-title":"Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas","volume":"69","author":"Davis","year":"2016","journal-title":"Histopathology"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/PAS.0000000000000926","article-title":"Primary renal sarcomas with BCOR-CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues","volume":"41","author":"Argani","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/his.14023","article-title":"Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults","volume":"76","author":"Yoshida","year":"2020","journal-title":"Histopathology"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/PGP.0000000000000301","article-title":"SATB2 expression is sensitive but not specific for osteosarcomatous components of gynecologic tract carcinosarcomas: a clinicopathologic study of 60 cases","volume":"36","author":"Sangoi","year":"2017","journal-title":"Int J Gynecol Pathol"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13569-020-00129-5","article-title":"Dedifferentiated soft tissue leiomyosarcoma with heterologous osteosarcoma component: case report and review of the literature","volume":"10","author":"Gaeta","year":"2020","journal-title":"Clin Sarcoma Res"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/PGP.0000000000000141","article-title":"Cellular mesenchymal tumors of the uterus: a review emphasizing recent observations","volume":"33","author":"Oliva","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.34","article-title":"A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer","volume":"106","author":"Eberhard","year":"2012","journal-title":"Br J Cancer"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1475-2867-9-18","article-title":"The mRNA expression of SATB1 and SATB2 in human breast cancer","volume":"9","author":"Patani","year":"2009","journal-title":"Cancer Cell Int"},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpobgyn.2011.06.002","article-title":"Prognostic factors in uterine sarcoma","volume":"25","author":"Gadducci","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R29-20250802","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/ajo.12245","article-title":"Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma","volume":"54","author":"Cade","year":"2014","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00428-018-2358-5","article-title":"Investigation of hormone receptor expression and its prognostic value in endometrial stromal sarcoma","volume":"473","author":"Park","year":"2018","journal-title":"Virchows Arch"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000730","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:05:36Z","timestamp":1754161536000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,13]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000730","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,13]]}}}